Atle Fund Management AB as of Sept. 30, 2025
Portfolio Holdings for Atle Fund Management AB
Atle Fund Management AB holds 38 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 11.2 | $3.0M | 37k | 81.00 | |
| Abbvie (ABBV) | 8.4 | $2.3M | 92k | 24.58 | |
| Neurocrine Biosciences (NBIX) | 5.7 | $1.5M | 103k | 14.90 | |
| Merck & Co (MRK) | 5.3 | $1.4M | 161k | 8.91 | |
| Thermo Fisher Scientific (TMO) | 5.2 | $1.4M | 27k | 51.49 | |
| BeiGene Sponsored Ads (ONC) | 4.1 | $1.1M | 30k | 36.17 | |
| Bridgebio Pharma (BBIO) | 3.6 | $964k | 175k | 5.51 | |
| AmerisourceBergen (COR) | 3.5 | $949k | 29k | 33.18 | |
| Intuitive Surgical Com New (ISRG) | 3.5 | $936k | 20k | 47.48 | |
| Gilead Sciences (GILD) | 3.4 | $921k | 78k | 11.78 | |
| Boston Scientific Corporation (BSX) | 3.3 | $898k | 87k | 10.36 | |
| Stryker Corporation (SYK) | 3.3 | $894k | 23k | 39.25 | |
| Alkermes SHS (ALKS) | 3.0 | $805k | 253k | 3.18 | |
| Krystal Biotech (KRYS) | 2.9 | $791k | 42k | 18.74 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $739k | 18k | 41.58 | |
| Mirum Pharmaceuticals (MIRM) | 2.7 | $729k | 94k | 7.78 | |
| NewAmsterdam Pharma Co NV Ordinary Shares (NAMS) | 2.2 | $585k | 194k | 3.02 | |
| Irhythm Technologies (IRTC) | 2.0 | $548k | 30k | 18.26 | |
| Edwards Lifesciences (EW) | 2.0 | $542k | 66k | 8.26 | |
| Cardinal Health (CAH) | 1.9 | $505k | 30k | 16.66 | |
| UFP Technologies (UFPT) | 1.8 | $487k | 23k | 21.19 | |
| Merus N V (MRUS) | 1.8 | $480k | 48k | 10.00 | |
| Soleno Therapeutics (SLNO) | 1.6 | $432k | 60k | 7.18 | |
| Revolution Medicines (RVMD) | 1.6 | $423k | 85k | 4.96 | |
| Amgen (AMGN) | 1.5 | $414k | 14k | 29.96 | |
| Dexcom Com New (DXCM) | 1.3 | $363k | 51k | 7.14 | |
| Bicara Therapeutics (BCAX) | 1.3 | $342k | 204k | 1.68 | |
| Disc Medicine (IRON) | 1.2 | $321k | 46k | 7.02 | |
| UnitedHealth (UNH) | 1.1 | $298k | 14k | 21.70 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.0 | $269k | 92k | 2.93 | |
| Avidity Biosciences Ord (RNA) | 0.9 | $240k | 52k | 4.63 | |
| Corbus Pharmaceuticals Hldgs (CRBP) | 0.9 | $236k | 176k | 1.34 | |
| Arcellx Common Stock (ACLX) | 0.8 | $224k | 26k | 8.72 | |
| Summit Therapeutics (SMMT) | 0.8 | $203k | 93k | 2.19 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.8 | $202k | 1.2M | 0.17 | |
| Celcuity (CELC) | 0.7 | $195k | 37k | 5.24 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.6 | $167k | 765k | 0.22 | |
| Janux Therapeutics (JANX) | 0.5 | $129k | 50k | 2.59 |
